Development of a novel thymidylate synthase (TS) inhibitor capable of up-regulating P53 expression and inhibiting angiogenesis in NSCLC
Introduction: The development of a new type of Thymidylate synthase (TS) inhibitor that could inhibit cancer cells' proliferation and anti-angiogenesis is of great significance for cancer's clinical treatment. Objectives: Our research hopes to develop a TS inhibitor that is more effective...
Main Authors: | Xin-yang Li, De-pu Wang, Guo-qing Lu, Kai-li Liu, Ting-jian Zhang, Shuai Li, Kamara Mohamed O, Wen-han Xue, Xin-hua Qian, Fan-hao Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Journal of Advanced Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090123220301673 |
Similar Items
-
Berberine: A Potential Inhibitor of Dihydrofolate Reductase- Thymidylate Synthase (DHFR-TS) for Malaria
by: Yohanes Bare, et al.
Published: (2022-10-01) -
Thymidylate synthase inhibitors for thoracic tumors
by: Peters Godefridus J., et al.
Published: (2013-06-01) -
Targeting Methyltransferases in Human Pathogenic Bacteria: Insights into Thymidylate Synthase (TS) and Flavin-Dependent TS (FDTS)
by: Cecilia Pozzi, et al.
Published: (2019-04-01) -
Structural and Functional Characterization of the Human Thymidylate Synthase (hTS) Interface Variant R175C, New Perspectives for the Development of hTS Inhibitors
by: Cecilia Pozzi, et al.
Published: (2019-04-01) -
Association of Thymidylate Synthase (<i>TS</i>) Gene Polymorphisms with Incidence and Prognosis of Coronary Artery Disease
by: Jung Oh Kim, et al.
Published: (2023-08-01)